SWITCHDIN
1.10.2020 22:02:08 CEST | Business Wire | Press release
SwitchDin, an Australian energy management software company, has been retained by distribution networks, SA Power Networks and AusNet Services, to provide a global-first solution that will allow networks to create flexible solar export limits to accommodate the growth of rooftop solar photovoltaic (PV) systems that are connected to the grid.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005065/en/
The installation of PV systems is growing at a rate of more than 200,000 each year in Australia’s National Electricity Market (NEM), and distribution networks are reaching the limit of their ability to host rooftop solar in some areas. This flexible export capability will allow SA Power Networks and AusNet Services to offer an alternative to the strict export limits currently required to address these challenges, increasing the penetration of renewable energy, creating more value for customers and improving the security of the grid.
The project is backed with over A$2 million in direct funding by the Australian Renewable Energy Agency (ARENA), with additional financial contributions from SwitchDin, SA Power Networks, AusNet Services and inverter manufacturers involved in the program. A 12 month trial involving a group of 600 customers in South Australia and Victoria will test the viability of this approach so it can be offered as a standard service to solar customers in future.
SwitchDin will lead in the project’s integration architecture design and will provide the core software platform for SA Power Networks and AusNet Services to support the flexible export functionality, based on the international ‘Smart Grid’ standard IEEE 2030.5. The flexible export capability will be enabled for solar inverters through connection to SwitchDin’s Droplet controller devices, or by connection via the internet into SwitchDin’s IEEE 2030.5 utility server platform.
Dr Andrew Mears, CEO of SwitchDin said, “SwitchDin is proud to be developing the technology backbone of the Flexible Exports project in South Australia and Victoria. This is another example of how we are working with Australia’s most progressive network service companies and the world’s best inverter manufacturers to bring smart software solutions to maximise the value of distributed energy resources such as rooftop solar for consumers and energy service providers alike.
“SwitchDin’s goal is to deliver smarter and cheaper clean energy services on the grid for the benefit of everyone. In the Australian market, the pressing issue is high penetration of rooftop solar, but our platform can also support battery storage and key loads such as heat pumps and electric vehicles as part of a complete ‘energy flexibility’ toolkit.”
“We want more solar, not less,” said Paul Roberts, Manager Corporate Affairs at SA Power Networks. “SA Power Networks is passionate about supporting South Australia’s energy transition and we have a number of initiatives underway that have the potential to double the amount of renewable energy the SA electricity distribution network can accommodate over the next five years.”
“By working with SwitchDin and the other project partners, SA Power Networks and AusNet Services are paving the way for distribution networks to continue to host the rooftop solar systems being installed by customers whilst reducing the need for major investment in network upgrades. This is a winning value proposition for energy distribution network companies globally who are grappling with how to meet customers’ expectations to be more energy independent.”
Building on past successes
SwitchDin solves one of the great roadblocks faced by today’s electricity system, the management at-scale of many distributed energy resources such as small-scale solar, batteries and loads like electric vehicles and HVAC systems. The company’s technology bridges the gap between traditional energy utilities, manufacturers and energy end-users by bringing rich data, intelligence and real-time fleet control capabilities to these assets.
In addition to the Flexible Exports project, SwitchDin is actively working with utilities and equipment manufacturers from around the world to build the grid of the future. The company connects and manages distributed assets with its Droplet controllers and smart software and provides cloud-level orchestration using its StormCloud management platform. SwitchDin can connect with upstream third party and utility distribution management systems or energy trading tools to ensure a smooth transition to clean and affordable electricity.
Note to Editor: Hi-res images can be downloaded here .
About SwitchDin:
SwitchDin is an energy technology company that plays a critical role in the energy transition by making distributed energy resources (DERs) such as solar PV and battery storage smart, visible and controllable. SwitchDin is paving the way for the integration of more renewables into the world’s energy system. Working in collaboration with energy utilities, equipment manufacturers, technology providers and facility managers, SwitchDin’s virtual power plant and microgrid management platform delivers new partnerships that unlock value for everyone connected to the grid. www.switchdin.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201001005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
